Axinn Recognized Among the Best Antitrust Practices in NY by Global Competition Review Magazine
May 11, 2010
In its 11th annual guide to the world's leading competition law and economics practices, Global Competition Review Magazine ranked Axinn among the top antitrust practices in New York as part of its GRC 100: New York list. The ranked list of top antitrust practices considered antitrust deals, practice size and impact of antitrust litigation in 2010.
Global Competition Review Magazine noted Stephen Axinn as “fielding a stellar reputation” and highlighted that John DeQ Briggs “brings deep experience to the team.”
During the past year, Axinn’s team won a significant victory for Group Health Incorporated and the HIP foundation when a federal judge rejected a claim based on the upward pricing pressure test outlined in the federal government’s new merger guidelines; worked on the Anheuser-Busch/InBev brewer merger, and has been retained by food-packager Bemis for its acquisition of assets from Rio Tinto; partner John D. Harkrider represented Omnicare in its conspiracy claim against United Health; and parnter Michael L. Keeley successfully fought off videogamemaker Electronic Arts’s attempt to acquire rival Take-Two.
The 2011 GRC 100 Survey was published in February 2011.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
CCWC 22nd Annual Career Strategies Conference
Sponsorship
Fordham Competition Law Institute's 53rd Annual Conference on International Antitrust Law and Policy, and Antitrust Economics Workshop
Sponsorship
Antitrust
Women, Influence, & Power in Law Conference 2026
Sponsorship
Antitrust
IP Litigation North America Summit 2026
Sponsorship
Intellectual Property
HNBA/VIA Annual Convention 2026
Sponsorship
Antitrust
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
ABA 2026 Antitrust Global Seminar Series
Speaking Engagement
Antitrust
Axinn Attorneys Earn Top Honors in Best Lawyers 2027
News
Antitrust
DOJ's Antitrust Division Remains Interested in Your Private Litigation
Byline Articles
Antitrust
Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg
Deals & Cases
Antitrust

